Q1 2022 Holdings
Filed 2022-05-13 | 59 holdings | $22.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $14.1M | 120,000 | 63.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.3M | 125,000 | 19.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.7M | 100,000 | 7.7% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.7M | 777,610 | 7.5% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $338.7K | 750,000 | 1.5% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $19.9K | 220,000 | 0.1% |
| Morphic Hldg Inc | COM | 61775R105 | $18.7K | 465,654 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $14.9K | 924,147 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $13.9K | 247,000 | 0.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $13.8K | 845,155 | 0.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $11.8K | 174,500 | 0.1% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $11.5K | $11,000,000 | 0.1% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $10.6K | 160,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $9.6K | 207,500 | 0.0% |
| Springworks Therapeutics IncPut | COM | 85205L107 | $9.0K | 160,000 | 0.0% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $7.8K | $7,000,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $7.4K | 75,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.1K | 300,000 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $6.8K | 702,500 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $6.7K | 468,905 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP)Call | COM | 69353Y103 | $6.6K | 317,400 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $6.4K | 115,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $6.0K | 171,592 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $5.5K | 1,374,098 | 0.0% |
| Protagonist Therapeutics Inc(PTGX)Put | COM | 74366E102 | $5.1K | 215,900 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.8K | 300,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $4.7K | $10,000,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $4.4K | $7,500,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.1K | 600,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.0K | 1,272,244 | 0.0% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $3.5K | 55,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $3.2K | 30,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.0K | 300,000 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $2.9K | 300,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.6K | 100,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $2.5K | 70,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.4K | 80,000 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $2.4K | 559,019 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $2.4K | 70,000 | 0.0% |
| Relay Therapeutics Inc(RLAY)Call | COM | 75943R102 | $2.2K | 75,000 | 0.0% |
| Lantheus Hldgs Inc(LNTH)Put | COM | 516544103 | $2.2K | 40,000 | 0.0% |
| Aurinia Pharmaceuticals Inc(AUPH)Call | COM | 05156V102 | $2.2K | 175,000 | 0.0% |
| Beam Therapeutics Inc(BEAM)Call | COM | 07373V105 | $1.7K | 30,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $1.2K | 400,000 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $1.2K | 325,000 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $1.2K | 221,382 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $951 | 7,500 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $925 | 50,000 | 0.0% |
| Athersys Inc New(ATHXEUR)Put | COM | 04744L106 | $858 | 1,416,400 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $846 | 199,490 | 0.0% |